Applied Biosystems/U.S. Department of Defense Terminate Contract for Prototype Instrument System to Identify Infectious Diseases
Parties Could Not Agree on Further Development and Commercialization
Applied Biosystems, an Applera Corporation business, announced that its contract with the U.S. Department of Defense surrounding the development of a prototype instrument system to improve the way infectious diseases are identified for epidemiological and biosecurity purposes has been terminated for the convenience of the government. Though Applied Biosystems had successfully completed all technical milestones required to date in the contract, the action was taken by the government after Applied Biosystems and the U.S. Air Force were unable to agree on an approach for further development and commercialization of an instrument system that could be derived from an AB prototype instrument. Applied Biosystems anticipates no material financial impact from the contract termination.
Applied Biosystems expects that its biosecurity strategy will continue to focus on delivering early warning systems for detecting and tracking emerging natural and man-made pathogens in the environment, in agriculture, and in the animal and human food supply.
Other news from the department business & finance
